Dexona (Generic Dexamethasone Tablets) is a synthetic corticosteroid exhibiting both anti-inflammatory and immuno-suppressant properties. This medication is used to treat symptoms such as inflammation, certain immune disorders and in replacement therapy of an inactive or underactive adrenal gla...
Dexona (Generic Dexamethasone Tablets) is a synthetic corticosteroid exhibiting both anti-inflammatory and immuno-suppressant properties. This medication is used to treat symptoms such as inflammation, certain immune disorders and in replacement therapy of an inactive or underactive adrenal gland.
Generic Dexamethasone can be prescribed for skin allergies, asthma, leukaemia, blood disorders, selected rheumatic disorders, gastrointestinal disorders, skin problems, certain abnormal growths (cancers) and excessive calcium in the blood.
The dosage of Dexona tablets (Generic Dexamethasone
Tablets) is given below:
The recommended initial oral dosage of Generic Dexamethasone tablets
varies from 0.75 to 9 mg a day depending on the indication being treated.
It must be emphasized that dosage requirements are variable and must be
individualized on the basis of the disease under treatment and the response of
the patient.
After a favorable response is noted, the proper maintenance dosage should be
determined by decreasing the initial drug dosage in small decrements at
appropriate time intervals until the lowest dosage that maintains an adequate
clinical response is reached.
URL: https://www.clearskypharmacy.biz/dexamethasone-oral-tablets.html
Dexona Tablets (Generic Dexamethasone
Tablets) have to be stored at controlled room
temperature i.e. from 20°C to 25°C (68°F to
77°F) with excursions permitted between 15° to
30°C (59° to 86°F).
Keep this as well as all other medicines away
from children and pets.
URL: https://www.clearskypharmacy.biz/dexamethasone-oral-tablets.html
Alterations in Endocrine Function: Hypothalamic-pituitary adrenal (HPA)
axis suppression, Cushing’s syndrome, and hyperglycemia can occur.
Monitor patients for these conditions with chronic use.
Immunosuppression and Increased Risk of Infections: Increased risk of
new, exacerbation, dissemination, or reactivation of latent infections.
Alteration in Cardiovascular/Renal Function: Monitor for elevated blood
pressure and sodium, and for decreased potassium levels.
Venous and Arterial Thromboembolism: Risk increased; consider
anticoagulant prophylaxis and monitor for evidence of thromboembolism.
Vaccination: Avoid the administration of live or live attenuated vaccines in
patients receiving immunosuppressive doses of corticosteroids.
Ophthalmic Effects: May include cataracts, infections, and glaucoma.
Gastrointestinal Perforation: Avoid use in active or latent peptic ulcers,
diverticulitis, fresh intestinal anastomoses, and nonspecific ulcerative
colitis, since they may increase the risk of a perforation.
Osteoporosis: Increased risk; monitor for changes in bone density with
chronic use.
Behavioral and Mood Disturbances: May include euphoria, insomnia,
mood swings, personality changes, severe depression, and psychosis.
Monitor for signs and symptoms and manage promptly.
Kaposi’s Sarcoma: Kaposi’s sarcoma has been reported to occur in patients
receiving corticosteroid therapy, most often for chronic conditions.
Embryo-Fetal Toxicity: Can cause fetal harm. Advise females of
reproductive potential of the potential risk to a fetus.